E. Garry Menzel - Insider Trading & Ownership

Entity
Individual
Location
C/O Regulus Therapeutics Inc., 3545 John Hopkins Court Suite 210, San Diego, CA
Summary
The estimated net worth of E. Garry Menzel is at least $50.5K dollars as of July 1, 2024. E. Garry Menzel is the Director of Adaptimmune Therapeutics PLC and owns shares of Adaptimmune Therapeutics PLC (ADAP) stock worth about $50.5K.
All Insider Reports
All Insider Reports

Ownership of E. Garry Menzel

Insider Transactions Reported by E. Garry Menzel:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.